Table 3.
Effect of treatments on the blood lipid profile, BMI, body composition and VO2max.
| Variable | Systematic Physical Exercise Program (N = 28) | |||||
|---|---|---|---|---|---|---|
| S. maxima Supplementation | Placebo Supplementation | |||||
| Basal | Final | p-Value | Basal | Final | p-Value | |
| BMI (kg·m−2) | 29.6 ± 3 | 28.9 ± 3 | 0.359 | 29.7 ± 3 | 29.4 ± 3 | 0.755 |
| Body fat (%) | 26.4 ± 7 | 25.2 ± 6 | 0.493 | 27.0 ± 7 | 26.0 ± 7 | 0.592 |
| TC (mg·dL−1) | 196.3 ± 35 | 162.6 ± 33 | 0.001 | 197.0 ± 38 | 177.2 ± 36 | 0.053 |
| TAG (mg·dL−1) | 157.3 ± 47 | 134.8 ± 37 | 0.070 | 139.3 ± 44 | 124.2 ± 42 | 0.212 |
| LDL-C (mg·dL−1) | 127.9 ± 36 | 93.3 ± 34 | 0.001 | 137.4 ± 38 | 115.4 ± 36 | 0.046 |
| HDL-C (mg·dL−1) | 34.4 ± 9 | 41.7 ± 10 | 0.005 | 31.4 ± 9 | 36.2 ± 9 | 0.059 |
| VO2max (mL·min−1 kg−1) |
37.0 ± 7 | 39.5 ± 7 | 0.212 | 36.6 ± 8 | 38.2 ± 7 | 0.486 |
| Variable | No exercise program (N = 24) | |||||
| S. maxima Supplementation | Placebo Supplementation | |||||
| Basal | Final | p-Value | Basal | Final | p-Value | |
| BMI (kg·m−2) | 30.8 ± 5 | 30.2 ± 5 | 0.709 | 30.9 ± 5 | 30.8 ± 5 | 0.945 |
| Body fat (%) | 31.3 ± 7 | 30.0 ± 7 | 0.551 | 31.2 ± 7 | 30.9 ± 7 | 0.917 |
| TC (mg·dL−1) | 201.2 ± 39 | 183.0 ± 37 | 0.103 | 190.2 ± 31 | 185.7 ± 31 | 0.619 |
| TAG (mg·dL−1) | 141.4 ± 37 | 127.3 ± 34 | 0.176 | 131.2 ± 31 | 125.1 ± 32 | 0.517 |
| LDL-C (mg·dL−1) | 138.0 ± 37 | 117.2 ± 38 | 0.062 | 131.3 ± 32 | 127.4 ± 30 | 0.680 |
| HDL-C (mg·dL−1) | 34.9 ± 10 | 40.3 ± 11 | 0.071 | 35.3 ± 12 | 36.7 ± 8 | 0.655 |
| VO2max (mL·min−1 kg−1) |
33.6 ± 6 | 35.4 ± 7 | 0.399 | 33.7 ± 6 | 34.2 ± 6 | 0.796 |
Data are expressed as mean ± SD. BMI: body mass index, VO2max: maximal oxygen uptake, TC: total cholesterol, TAG: triacylglycerols; LDL-C: low-density lipoprotein-cholesterol, HDL-C: high-density lipoprotein-cholesterol; N: sample size.